Article

How full is our antihypertensives pipeline?

Dilip Gude1★★ Corresponding author

  1. 1Department of Internal Medicine, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India.

CORRESPONDENCE

Dilip Gude

Department of Internal Medicine, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India.

letsgo.dilip@gmail.com

Volume 3, Issue 1 · pp. 7–8 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.92492

View on JPP original site ↗

ABSTRACT

We have a plethora of new antihypertensives coming up with diverse mechanisms of action but if that would drastically change and better the management of hypertension remains to be seen. A review of the newer classes of antihypertensives in the pipeline is presented.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Gude, D. (2012). How full is our antihypertensives pipeline?. Journal of Pharmacology and Pharmacotherapeutics, 3(1), 7–8. https://doi.org/10.4103/0976-500X.92492